期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Drug-and cell-based therapies for targeting neuroinflammation in traumatic brain injury 被引量:3
1
作者 Sussannah Kaelber Paolina Pantcheva Cesar V.Borlongan 《Neural Regeneration Research》 SCIE CAS CSCD 2016年第10期1575-1576,共2页
TBI pathology: Traumatic brain injury (TBI) is caused by an external force to the head, resulting in trauma to the brain. Approximately 1.7 million Americans suffer from TBI every year. Out of the 1.7 million suffe... TBI pathology: Traumatic brain injury (TBI) is caused by an external force to the head, resulting in trauma to the brain. Approximately 1.7 million Americans suffer from TBI every year. Out of the 1.7 million suffering from TBI, an estimated 52,000 injuries result in death, leaving a mass amount of peo- ple with symptoms that could last a few days, a few years, or their entire life (Faul et al., 2010). TBI can be classified as mild, moderate and severe. Depending on the classification and the extent of the injury, TBI can cause both physical symptoms and cognitive disorders (Lozano et al., 2015). 展开更多
关键词 TBI cell drug-and cell-based therapies for targeting neuroinflammation in traumatic brain injury
在线阅读 下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部